Medication info
Ogme Tablet 625 mg (Amoxicillin-Potassium Clavulanate)

Ogme Tablet 625 mg (Amoxicillin-Potassium Clavulanate)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
(Yoo) Hanpoong Pharmaceutical Co., Ltd.
Appearance
White or almost white oval film-coated tablet
Packaging
40 tablets/box [4 tablets/PTP*10]
Approval status
Active

MFDS item code 201905431 · Approved 2019.07.31 · Insurance code 658106870

Summary

Main use
Treatment of respiratory and ear infections, genitourinary infections, and skin, soft tissue, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults and children aged 12 years and older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally 3 times a day, every 8 hours. The dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is required for patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)
Child dose
Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
(Yoo) Hanpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear infections, genitourinary infections, and skin, soft tissue, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infection
View approved original text

This medication is effective against various bacteria and is used for treating respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, and lung abscess. It is also effective against infections such as tonsillitis, sinusitis, and otitis media. It is suitable for treating urogenital infections like cystitis, urethritis, and pyelonephritis, and is used in sexually transmitted diseases such as pelvic infections and gonorrhea. It is effective for skin and soft tissue infections including furunculosis, abscess, soft tissue infections, wound infections, and osteomyelitis. It is also used in dental infections, providing assistance for a wide range of infectious diseases. It is safely and effectively used for the treatment of various infections.

How to take

Adult dose

The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults and children aged 12 years and older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally 3 times a day, every 8 hours. The dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is required for patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)

Child dose

Children: Reduce the dose in the same manner.

Precautions

This drug is a beta-lactam antibacterial agent belonging to the penicillin class and should not be administered to patients with a history of specific allergic reactions. In particular, individuals who have experienced hypersensitivity to this drug or similar class medications should avoid use, and caution is needed for patients with infectious mononucleosis or lymphocytic leukemia. Those with liver function problems should use this drug cautiously, as it may worsen liver function during use. Additionally, patients with moderate to severe renal impairment may need to adjust the dosing intervals due to increased drug blood levels. Those with allergic predisposition, elderly patients, or patients with poor general health also need to exercise caution due to the risk of side effects. This drug can cause various gastrointestinal side effects, and if symptoms such as abdominal pain, diarrhea, or vomiting occur, immediate consultation with medical personnel is required. Should symptoms of hypersensitivity arise, such as liver dysfunction, severe skin rash, or difficulty breathing, administration should be stopped immediately, and medical help should be sought. Prolonged use may result in the development of resistant bacteria and the proliferation of non-susceptible strains, hence should only be used for the necessary duration, with regular checks on liver and kidney function and blood tests. This medication may interact with other drugs, so it is essential to inform medical personnel of any concurrent medications. Pregnant or breastfeeding women should avoid this drug unless absolutely necessary, as it may affect the fetus or infant. In children or elderly patients, dosage and interval should be adjusted according to weight and health status, and side effects should be monitored closely. Overdose may lead to gastrointestinal symptoms or kidney damage, as well as central nervous system abnormalities, requiring immediate medical treatment. When storing, avoid direct sunlight and keep in a cool, dry place, and it is crucial to consult a doctor or pharmacist before use.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, soft stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-associated colitis, hematochezia, itching, polymorphic eruption of the gums, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchial spasm, dyspnea, laryngeal edema, anaphylactic shock, leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, vaginal pain, increased secretion, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, seizures, antiparkinsonian action, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B complex deficiency, linear IgA disease, dysgeusia, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial cerebral seizures, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be kept in a sealed container to prevent moisture and air infiltration, stored at a cool temperature between 1 degree and 25 degrees. This will maintain the drug's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

White or almost white oval film-coated tablet

Package unit

40 tablets/box [4 tablets/PTP*10]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.